QSV Equity Investors LLC Buys 10,190 Shares of Astrana Health, Inc. $ASTH

QSV Equity Investors LLC increased its stake in Astrana Health, Inc. (NASDAQ:ASTHFree Report) by 34.4% in the first quarter, HoldingsChannel reports. The fund owned 39,786 shares of the company’s stock after purchasing an additional 10,190 shares during the period. QSV Equity Investors LLC’s holdings in Astrana Health were worth $1,234,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. raised its position in Astrana Health by 4.5% during the 1st quarter. Vanguard Group Inc. now owns 4,898,992 shares of the company’s stock valued at $151,918,000 after purchasing an additional 213,033 shares during the last quarter. Dimensional Fund Advisors LP raised its position in Astrana Health by 10.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,045,540 shares of the company’s stock valued at $32,968,000 after purchasing an additional 101,192 shares during the last quarter. 325 Capital LLC raised its position in Astrana Health by 30.3% during the 4th quarter. 325 Capital LLC now owns 886,916 shares of the company’s stock valued at $27,964,000 after purchasing an additional 206,009 shares during the last quarter. SteelPeak Wealth LLC raised its position in Astrana Health by 4.8% during the 1st quarter. SteelPeak Wealth LLC now owns 568,176 shares of the company’s stock valued at $17,619,000 after purchasing an additional 26,192 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in Astrana Health by 6.0% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 499,529 shares of the company’s stock valued at $15,490,000 after purchasing an additional 28,200 shares during the last quarter. Institutional investors own 52.77% of the company’s stock.

Astrana Health Trading Down 0.7%

ASTH opened at $29.33 on Monday. The business has a 50 day simple moving average of $24.87 and a two-hundred day simple moving average of $28.80. The firm has a market capitalization of $1.64 billion, a price-to-earnings ratio of 57.51, a PEG ratio of 0.73 and a beta of 0.85. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.59 and a quick ratio of 1.59. Astrana Health, Inc. has a one year low of $21.20 and a one year high of $63.20.

Astrana Health (NASDAQ:ASTHGet Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.36 by ($0.17). Astrana Health had a return on equity of 3.43% and a net margin of 1.04%. The firm had revenue of $654.81 million during the quarter, compared to the consensus estimate of $639.13 million. During the same period in the prior year, the company posted $0.40 EPS. The firm’s revenue was up 34.7% on a year-over-year basis. Analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current year.

Astrana Health Profile

(Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Featured Stories

Want to see what other hedge funds are holding ASTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astrana Health, Inc. (NASDAQ:ASTHFree Report).

Institutional Ownership by Quarter for Astrana Health (NASDAQ:ASTH)

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.